Drug
Fdc Laroprovstat Rosuvastatin 1
Fdc Laroprovstat Rosuvastatin 1: highest development phase Phase 3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| FDC laroprovstat/Rosuvastatin 1 NCT07930507 | Phase 3 | Hypercholesterolemia |
Latest
No recent events.
Follow Fdc Laroprovstat Rosuvastatin 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.